Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.4M | $643,000 | $1.0M | $1.2M | — |
| Gross profit | −$503,000 | −$281,000 | −$129,000 | −$360,000 | — |
| Research & development | $1.5M | $1.5M | $2.1M | $1.6M | — |
| Operating expenses | $9.2M | $9.3M | $6.7M | $7.4M | $421,397 |
| Operating income | −$9.7M | −$9.6M | −$6.9M | −$7.7M | −$585,405 |
| EBITDAderived | −$9.6M | −$9.5M | −$6.8M | −$7.7M | — |
| Net income | −$2.8M | −$10.1M | −$33.8M | −$30.5M | $5.1M |
| Basic EPSper diluted share | -$0.06 | -$0.36 | -$4.65 | -$7.66 | — |
| Diluted EPSper diluted share | -$0.06 | -$0.36 | -$4.65 | -$7.66 | $0.44 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 23, 2026Form 4 | Green AaronChief Executive Officer | BuyCommon Stock | 36.6K | $0.57 | $20.9K | 1.90M |
| Jun 23, 2026Form 4 | Yu JeffreyChief Medical Officer | BuyCommon Stock | 158.7K | $0.63 | $100.0K | 8.78M |
| Jun 16, 2026Form 4 | Yu JeffreyChief Medical Officer | BuyCommon Stock | 172.4K | $0.58 | $100.0K | 8.62M |
| Jun 15, 2026Form 4 | Green AaronChief Executive Officer | BuyCommon Stock | 18.7K | $0.54 | $10.1K | 1.86M |
| Jun 12, 2026Form 4 | Green AaronChief Executive Officer | BuyCommon Stock | 36.9K | $0.56 | $20.7K | 1.84M |